LobbyingTeam Vaccinate lobbying by quarter
Team Vaccinate's latest lobbying report covers Q4 2023, at under $5,000. Its first report covers Q4 2023; the issues it reports most are Health Issues.
Team Vaccinate
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $0
- Last 4 quarters
- vs last quarter
- No record
- Q3 2026 against the quarter before
- First report
- Q4 2023
- The first quarter a report named it
Lobbying by quarter
No lobbying spend in this period.
| Quarter | Amount | Reports |
|---|---|---|
| Q4 2023 | $0 | 1 |
| Q1 2024 | $0 | 0 |
| Q2 2024 | $0 | 0 |
| Q3 2024 | $0 | 0 |
| Q4 2024 | $0 | 0 |
| Q1 2025 | $0 | 0 |
| Q2 2025 | $0 | 0 |
| Q3 2025 | $0 | 0 |
| Q4 2025 | $0 | 0 |
| Q1 2026 | $0 | 0 |
| Q2 2026 | $0 | 0 |
| Q3 2026 | $0 | 0 |
By issue
- Health issues$0 · 1 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- Centers For Disease Control & Prevention (CDC)1 reports
- Food & Drug Administration (FDA)1 reports
- HOUSE OF REPRESENTATIVES1 reports
- Natl Institute of Mental Health (NIMH)1 reports
- SENATE1 reports
Firms it paid
| Firm | ||
|---|---|---|
| In-houseTeam Vaccinate | $0 | 1 quarters |
Former officials lobbying for it
| Former position | ||
|---|---|---|
| ROBERT HOUTON | not applicable | Q4 2023 |
Lobbying reports
| Filed by | ||
|---|---|---|
| 24/02/05for Q4 2023 | In-house | Under $5,000 |
| 24/01/20for Q4 2023 | In-house | Under $5,000 |